Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) NSAIDs like ibuprofen or aspirin weaken the protective layer of the stomach lining, increasing the damage caused by stomach acids.

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...

Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a ...

The plaintiffs claim that they developed cancer due to the medication Zantac, which is used to relieve acid reflux and heartburn. The complaint names Boehringer Ingelheim Pharmaceuticals Inc ...

A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain ...

One of the doctors charged in the drug-related death of actor Matthew Perry last year has appeared in a US court. Mark Chavez was bailed at the hearing in Los Angeles on Friday during which he ...

It’s also a way of identifying some internal diseases. For example, many of us will be familiar with the pesky mouth ulcer. They’re very common and often found on the internal lining of the ...

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused ...

The drug makers argued the testimony was not supported by sound scientific methods. The main concerns revolve around ranitidine, Zantac's active ingredient, which is believed to potentially ...

WASHINGTON (Reuters) -More than 1 million people in the U.S. will save over $1,000 a year beginning in 2025, when an annual $2,000 cap on prescription drug out-of-pocket costs kicks in ...